Description
Conecsio cuts the risk and cost of a clinical trial before capital is committed.
Our AI-powered platform has three complementary solutions across the sequence where trial value is lost:
- Dataloom unlocks Europe's secondary-use health data, connecting data holders with the researchers who need it;
- ScreenAct identifies high-performing investigator sites and automates patient recruitment;
- Edop manages e-consent and improves patient retention.
Bpifrance Deeptech label · two-time France 2030 award winner with Unicancer · pre-seed backed by IRDI Capital Investissement.
